Labroots

Automating NGS sample preparation to accelerate microbiome research

Automating NGS sample preparation to accelerate microbiome research Microbiome research often involves complex workflows and ...
Labroots

Accelerating Control of Drug-resistant Tuberculosis with Targeted Next-generation Sequencing: Country Success Stories from the Front Lines

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people each year and caused and estimated 1.25 million deaths in 2023. 1,2 While ...
Business Wire

Ambry Genetics Publishes Data from 20,000 Cases Supporting Sanger Sequencing of Variants Following NGS

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (“Ambry”) today publishes data in The Journal of Molecular Diagnostics from the largest study to date 1, 20,000 cases submitted for hereditary ...
Business Wire

Summit Health Announces Internalization of Genomic Testing Cooperative State-of-The-Art Next Generation Sequencing DNA and RNA Profiling Tests for Tissue and Liquid Biopsy of ...

LAKE FOREST, Calif. & WOODLAND PARK, N.J.--(BUSINESS WIRE)--Summit Health, part of Village MD and Genomic Testing Cooperative (GTC), the global leader in RNA innovation, are excited to announce today ...

Illumina (ILMN), Labcorp (LH) expand precision oncology NGS collaboration

Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March ...
technologynetworks

Implementation of Next-Generation Sequencing in the Clinical Microbiology Lab

This webinar will be hosted in Spanish. Next generation sequencing (NGS) is rapidly transforming the detection and characterization of infectious organisms by enabling faster, more comprehensive ...
MarketWatch

Pillar Biosciences' FDA Approved Solid Tumor NGS Kit oncoReveal(TM) CDx Launched at Molecular Pathology Laboratory Network, Inc.

NATICK, Mass., July 30, 2024 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine(TM), has announced that Molecular Pathology Laboratory Network, Inc., (MPLN) is now the first ...
MobiHealthNews

China’s Burning Rock Biotech completes Series C financing of RMB 850 million

Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C ...